Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer have?
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer has 724 citations in the OpenAlex counts ScholarIQ stores.
When was Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer published?
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer has 2023 year in the ScholarIQ index.
What is the open-access status of Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer?
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer has green oa status in the ScholarIQ index.
What is the DOI of Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer?
The DOI for Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer is on the source record.
What is the PMID of Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer?
The PMID for Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer?
The OpenAlex for Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer is on the source record.